John Mamo
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 45
- Diet, Metabolism, and Disease 12
- Neurology top 2%
- Physiology top 1%
- Alzheimer's disease research and treatments 27
- Diet and metabolism studies 20
- Biological Psychiatry top 5%
- Biochemistry top 2%
-
- Lipid metabolism and disorders 32
-
- Lipoproteins and Cardiovascular Health 24
- Cholesterol and Lipid Metabolism 14
-
- Cancer, Lipids, and Metabolism 15
- Co-authors
- Spencer D. ProctorRyusuke TakechiVirginie LamSebely PalAnthony P. JamesGerald F. WattsDonna F. VineMenuka M. Pallebage‐Gamarallage
In The Last Decade
John Mamo
195 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 147
- Endocrinology, Diabetes and Metabolism 1.7k
- Neurology 519
- Physiology 1.5k
- Biological Psychiatry 127
- Biochemistry 301
Countries citing papers authored by John Mamo
This map shows the geographic impact of John Mamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mamo more than expected).
Fields of papers citing papers by John Mamo
This network shows the impact of papers produced by John Mamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mamo. The network helps show where John Mamo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Mamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 4 | |
| 7 | ARDS and systemic sepsis from Actinomycosis related IUCD infection | 2020 | 0 |
| 8 | 2020 | 10 | |
| 9 | 2019 | 2 | |
| 10 | 2017 | 7 | |
| 11 | 2016 | 8 | |
| 12 | 2015 | 228 | |
| 13 | 2009 | 64 | |
| 14 | 2009 | 38 | |
| 15 | 2002 | 163 | |
| 16 | 2001 | 26 | |
| 17 | 2000 | 27 | |
| 18 | 1991 | 28 | |
| 19 | 1990 | 41 | |
| 20 | [Value of calcium gluconate labelled with 99mTc in the detection of intracranial tumors]. | 1975 | 2 |
About John Mamo
John Mamo is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology, Physiology, Nutrition and Dietetics and Cardiology and Cardiovascular Medicine, having authored 205 papers that have together received 5.3k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers), Lipid metabolism and disorders (32 papers), Alzheimer's disease research and treatments (27 papers), Lipoproteins and Cardiovascular Health (24 papers), Diet and metabolism studies (20 papers), Cancer, Lipids, and Metabolism (15 papers), Cholesterol and Lipid Metabolism (14 papers) and Diet, Metabolism, and Disease (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Neurology (519 citations), Physiology (1.5k citations), Biological Psychiatry (127 citations) and Biochemistry (301 citations). John Mamo has collaborated with scholars based in Australia, Canada and Japan. Frequent co-authors include Spencer D. Proctor, Ryusuke Takechi, Virginie Lam, Sebely Pal, Anthony P. James, Gerald F. Watts, Donna F. Vine, Menuka M. Pallebage‐Gamarallage, Satvinder S. Dhaliwal and Corey Giles. Their work appears in journals such as Atherosclerosis, Lipids in Health and Disease, Annals of Clinical Biochemistry International Journal of Laboratory Medicine, European Journal of Clinical Investigation and Atherosclerosis Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.